Passage Bio Inc (PASG)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
総売上 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
営業利益 | -28.24M | -35.88M | -25.39M | -23.28M | -18.45M | -18.05M | -16.94M | -15.91M |
税引前収入 | -27.07M | -34.34M | -23.86M | -27.11M | -16.76M | -16.71M | -15.99M | -19.34M |
純利益 | -27.07M | -34.34M | -23.86M | -27.11M | -16.76M | -16.71M | -15.99M | -19.34M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -28.24M | -34.34M | -23.86M | -21.72M | -22.36M | -16.71M | -15.55M | -14.55M |
EBITDA | -27.3M | -34.91M | -24.41M | -22.32M | -17.64M | -17.24M | -16.14M | -15.15M |
年末 2023年12月31日 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 0 | 0 | 0 |
営業利益 | -13.47M | -37.19M | -112.9M | -185.73M | -138.39M | -103M |
税引前収入 | -12.77M | -45.63M | -112.23M | -185.39M | -136.13M | -102.06M |
純利益 | -12.77M | -45.63M | -112.23M | -185.39M | -136.13M | -102.06M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -0.687 | -2.398 | -2.46 | -3.418 | -2.492 | -1.862 |
EBIT | -12.77M | -46.33M | -112.9M | -185.73M | -138.39M | -102.27M |
EBITDA | -13.47M | -37.06M | -112.1M | -184.19M | -134.72M | -99.28M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約